文献
J-GLOBAL ID:201002288242195635
整理番号:10A0172622
siRNA送達用の陽イオン性脂質の合理的な設計
Rational design of cationic lipids for siRNA delivery
著者 (40件):
SEMPLE Sean C
(Tekmira Pharmaceuticals, British Columbia, CAN)
,
AKINC Akin
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
CHEN Jianxin
(Tekmira Pharmaceuticals, British Columbia, CAN)
,
SANDHU Ammen P
(Tekmira Pharmaceuticals, British Columbia, CAN)
,
MUI Barbara L
(Tekmira Pharmaceuticals, British Columbia, CAN)
,
CHO Connie K
(Tekmira Pharmaceuticals, British Columbia, CAN)
,
SAH Dinah W Y
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
STEBBING Derrick
(Tekmira Pharmaceuticals, British Columbia, CAN)
,
CROSLEY Erin J
(Tekmira Pharmaceuticals, British Columbia, CAN)
,
YAWORSKI Ed
(Tekmira Pharmaceuticals, British Columbia, CAN)
,
HAFEZ Ismail M
(Univ. British Columbia, British Columbia, CAN)
,
DORKIN J Robert
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
QIN June
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
LAM Kieu
(Tekmira Pharmaceuticals, British Columbia, CAN)
,
RAJEEV Kallanthottathil G
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
WONG Kim F
(Univ. British Columbia, British Columbia, CAN)
,
JEFFS Lloyd B
(Tekmira Pharmaceuticals, British Columbia, CAN)
,
NECHEV Lubomir
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
EISENHARDT Merete L
(Tekmira Pharmaceuticals, British Columbia, CAN)
,
JAYARAMAN Muthusamy
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
KAZEM Mikameh
(Univ. British Columbia, British Columbia, CAN)
,
MAIER Martin A
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
SRINIVASULU Masuna
(Univ. British Columbia, British Columbia, CAN)
,
WEINSTEIN Michael J
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
CHEN Qingmin
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
ALVAREZ Rene
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
BARROS Scott A
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
DE Soma
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
KLIMUK Sandra K
(Tekmira Pharmaceuticals, British Columbia, CAN)
,
BORLAND Todd
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
KOSOVRASTI Verbena
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
CANTLEY William L
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
TAM Ying K
(Tekmira Pharmaceuticals, British Columbia, CAN)
,
MANOHARAN Muthiah
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
CIUFOLINI Marco A
(Univ. British Columbia, British Columbia, CAN)
,
TRACY Mark A
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
DE FOUGEROLLES Antonin
(Alnylam Pharmaceuticals, Massachusetts, USA)
,
MACLACHLAN Ian
(Tekmira Pharmaceuticals, British Columbia, CAN)
,
CULLIS Pieter R
(Univ. British Columbia, British Columbia, CAN)
,
MADDEN Thomas D
(Tekmira Pharmaceuticals, British Columbia, CAN)
資料名:
Nature Biotechnology
(Nature Biotechnology)
巻:
28
号:
2
ページ:
172-176
発行年:
2010年02月
JST資料番号:
H0870A
ISSN:
1087-0156
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)